Biocure Cuts Acquisition Share Consideration, Extends Deadline

Biocure amended its agreement to acquire Glorious Success Limited, reducing share consideration from 12,459,091 to 11,325,464 shares and extending the deadline from December 31, 2026 to January 31, 2027. The transaction remains subject to approvals and other conditions.